Speciality Medicines Limited (BOM:544738)

Speciality Medicines Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	752.85	752.85	582.71	275.25	232.41	404.44
Revenue Growth	86.15%	29.20%	111.71%	18.43%	-42.54%	-
Gross Profit Gross Profit Growth	211.53	211.53	160.81	93.16	69.4	53.87
Operating Income Operating Income Growth	135.09	135.09	89.55	50.29	33.14	21.64
Net Income Net Income Growth	130.33	130.33	71.96	40.51	22.01	14.79
Earnings Per Share EPS Growth	20.11	20.11	11.18	7.92	6.15	4.87
EPS Growth	313.13%	79.88%	41.21%	28.74%	26.34%	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	179.88	116.98	66.85	362.36
Export Export Growth	402.83	158.27	165.56	42.08
Total Total Growth	582.71	275.25	232.41	404.44

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	245.46	245.46	8.46	2.49	2.62	0.77
Total Debt Total Debt Growth	66.42	66.42	50.47	28.58	36.4	11.78
Net Cash (Debt) Net Cash Growth	179.03	179.03	-42.01	-26.09	-33.78	-11.01
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	27.63	27.63	-6.53	-5.10	-9.44	-3.62

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-12.81	-12.81	-64.32	-48	-36.89	8.06
Capital Expenditures CapEx Growth	-0.08	-0.08	-6.07	-0.25	-0.8	-20.93
Free Cash Flow Free Cash Flow Growth	-12.89	-12.89	-70.39	-48.25	-37.69	-12.87
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	28.10%	28.10%	27.60%	33.85%	29.86%	13.32%
Operating Margin	17.94%	17.94%	15.37%	18.27%	14.26%	5.35%
Pretax Margin	17.29%	17.29%	14.91%	14.61%	12.74%	5.29%
Profit Margin	17.31%	17.31%	12.35%	14.72%	9.47%	3.66%
FCF Margin	-1.71%	-1.71%	-12.08%	-17.53%	-16.22%	-3.18%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	8.86	8.49	-	-	-	-
PS Ratio	2.08	1.47	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error